Advertisement

FDA Approves Return of Primatene Mist Asthma Inhaler

FDA Approves Return of Primatene Mist Asthma Inhaler

Created: November 08, 2018 04:16 PM

LINDA A. JOHNSON, AP Medical Writer

Advertisement – Content Continues Below

TRENTON, N.J. (AP) - A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.

The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It's for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up.

The original Primatene Mist was pulled from store shelves seven years ago because the inhaler's ozone-depleting propellant had been banned. That version had been marketed for half a century, including in memorable TV ads .

The new product from Amphastar Pharmaceuticals uses a safer propellant. The inhaler will cost about $25 and should be available by the end of the year.

The FDA said in a statement that the inhaler should not be substituted for prescription treatments or used by people with severe asthma.

Copyright 2018 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Barr: Not Enough Evidence of Trump Obstruction

Hungry Wolves Relocated to Isle Royale National Park

Hope for Gubernatorial Pardons Renewed in Wisconsin

Study: Minnesota Sees Jump in Homelessness Since 2015

Charges: UMN Worker Stole $134,000 in Computers from School

Superior Joins $18M Cleanup of Howards Bay Contamination

Advertisement